Home › Funds › HOMESTEAD ADVISERS CORP › BSX
HOMESTEAD ADVISERS CORP position in BSX
BOSTON SCIENTIFIC CORP · Health Care
HOMESTEAD ADVISERS CORP reported holding 885,962 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$38.7M, representing 0.98% of its reported portfolio and ranking #41 among its reported holdings. HOMESTEAD ADVISERS CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HOMESTEAD ADVISERS CORP's BSX position evolved
HOMESTEAD ADVISERS CORP first disclosed a stake in BSX in Q3 2023 at 1,640,626 shares (US$86.6M). The position peaked in Q1 2024 at 1,578,926 shares, worth US$108.2M. Across 13 filings, HOMESTEAD ADVISERS CORP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 885,962 shares valued at US$38.7M — an increase of 333,900 shares quarter over quarter.. Notable position changes include a 72% increase in Q1 2026 (shares fell 32% over the following quarter), a 41% trim in Q2 2026 (shares rose 2% over the following quarter), a 60% increase in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.64M | $86.63M | New |
| Q4 2023 | 1.64M | $95.01M | Hold |
| Q1 2024 | 1.58M | $108.18M | Reduce |
| Q2 2024 | 1.34M | $103.08M | Reduce |
| Q3 2024 | 1.14M | $95.18M | Reduce |
| Q4 2024 | 1.18M | $105.36M | Add |
| Q1 2025 | 982.53K | $99.12M | Reduce |
| Q2 2025 | 759.43K | $81.57M | Reduce |
| Q3 2025 | 668.43K | $65.26M | Reduce |
| Q4 2025 | 547.06K | $52.16M | Reduce |
| Q1 2026 | 942.06K | $59.14M | Add |
| Q2 2026 | 552.06K | $23.56M | Reduce |
| Q3 2026 | 885.96K | $38.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on HOMESTEAD ADVISERS CORP
FAQ
How long has HOMESTEAD ADVISERS CORP held BSX?
HOMESTEAD ADVISERS CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HOMESTEAD ADVISERS CORP's current position in BSX?
As of Q3 2026, HOMESTEAD ADVISERS CORP holds 885.96K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $38.70M, representing 0.98% of its reported portfolio and ranking #41.
Has HOMESTEAD ADVISERS CORP been buying or selling BSX?
In the latest 13F filing (Q3 2026), HOMESTEAD ADVISERS CORP increased its position in BSX. The position peaked in Q1 2024 at 1.58M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.